| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Buprenorphine measurement |
Component |
True |
Buprenorphine (substance) |
Inferred relationship |
Some |
1 |
| Buprenorphine poisoning (disorder) |
Causative agent |
True |
Buprenorphine (substance) |
Inferred relationship |
Some |
1 |
| Accidental buprenorphine poisoning |
Causative agent |
False |
Buprenorphine (substance) |
Inferred relationship |
Some |
|
| Intentional buprenorphine poisoning |
Causative agent |
False |
Buprenorphine (substance) |
Inferred relationship |
Some |
|
| buprenorfinförgiftning, med oklar avsikt |
Causative agent |
False |
Buprenorphine (substance) |
Inferred relationship |
Some |
1 |
| Buprenorphine adverse reaction |
Causative agent |
True |
Buprenorphine (substance) |
Inferred relationship |
Some |
1 |
| Allergy to buprenorphine (finding) |
Causative agent |
False |
Buprenorphine (substance) |
Inferred relationship |
Some |
|
| Buprenorphine overdose |
Causative agent |
True |
Buprenorphine (substance) |
Inferred relationship |
Some |
1 |
| Accidental buprenorphine overdose |
Causative agent |
True |
Buprenorphine (substance) |
Inferred relationship |
Some |
1 |
| Intentional buprenorphine overdose |
Causative agent |
True |
Buprenorphine (substance) |
Inferred relationship |
Some |
1 |
| överdos av buprenorfin, med oklar avsikt |
Causative agent |
False |
Buprenorphine (substance) |
Inferred relationship |
Some |
1 |
| Product containing buprenorphine (medicinal product) |
Has active ingredient |
True |
Buprenorphine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely buprenorphine (as buprenorphine hydrochloride) 400 microgram/1 each conventional release sublingual tablet (clinical drug) |
Has active ingredient |
False |
Buprenorphine (substance) |
Inferred relationship |
Some |
|
| Buprenorphine (as buprenorphine hydrochloride) 2 mg sublingual tablet |
Has active ingredient |
False |
Buprenorphine (substance) |
Inferred relationship |
Some |
|
| Product containing precisely buprenorphine (as buprenorphine hydrochloride) 8 milligram/1 each conventional release sublingual tablet (clinical drug) |
Has active ingredient |
False |
Buprenorphine (substance) |
Inferred relationship |
Some |
|
| Buprenorphine (as buprenorphine hydrochloride) 200 microgram sublingual tablet |
Has active ingredient |
False |
Buprenorphine (substance) |
Inferred relationship |
Some |
|
| buprenorfin 300 mikrogram/ml, injektionsvätska, lösning, ampull 1 ml |
Has active ingredient |
False |
Buprenorphine (substance) |
Inferred relationship |
Some |
|
| Buprenorphine product |
Has active ingredient |
False |
Buprenorphine (substance) |
Inferred relationship |
Some |
|
| Buprenorphine 70micrograms/hour transdermal patch |
Has active ingredient |
False |
Buprenorphine (substance) |
Inferred relationship |
Some |
|
| Buprenorphine 52.5micrograms/hour transdermal patch |
Has active ingredient |
False |
Buprenorphine (substance) |
Inferred relationship |
Some |
|
| Buprenorphine 35micrograms/hour transdermal patch |
Has active ingredient |
False |
Buprenorphine (substance) |
Inferred relationship |
Some |
|
| Buprenorphine hydrochloride + naloxone hydrochloride |
Has active ingredient |
False |
Buprenorphine (substance) |
Inferred relationship |
Some |
|
| buprenorfinhydroklorid 2 mg + naloxonhydroklorid 0,5 mg, resoriblett |
Has active ingredient |
False |
Buprenorphine (substance) |
Inferred relationship |
Some |
|
| buprenorfinhydroklorid 8 mg + naloxonhydroklorid 2 mg, resoriblett |
Has active ingredient |
False |
Buprenorphine (substance) |
Inferred relationship |
Some |
|
| Urine buprenorphine level (procedure) |
Component |
True |
Buprenorphine (substance) |
Inferred relationship |
Some |
2 |
| buprenorfin 35 mikrogram per timme, depåplåster |
Has active ingredient |
False |
Buprenorphine (substance) |
Inferred relationship |
Some |
|
| buprenorfin 52,5 mikrogram per timme, depåplåster |
Has active ingredient |
False |
Buprenorphine (substance) |
Inferred relationship |
Some |
|
| buprenorfin 70 mikrogram per timme, depåplåster |
Has active ingredient |
False |
Buprenorphine (substance) |
Inferred relationship |
Some |
|
| Serum buprenorphine level (procedure) |
Component |
True |
Buprenorphine (substance) |
Inferred relationship |
Some |
2 |
| Plasma buprenorphine level (procedure) |
Component |
True |
Buprenorphine (substance) |
Inferred relationship |
Some |
2 |
| Buprenorphine hydrochloride |
Is a |
False |
Buprenorphine (substance) |
Inferred relationship |
Some |
|
| Accidental buprenorphine poisoning |
Causative agent |
True |
Buprenorphine (substance) |
Inferred relationship |
Some |
1 |
| Intentional buprenorphine poisoning |
Causative agent |
True |
Buprenorphine (substance) |
Inferred relationship |
Some |
1 |
| Product containing buprenorphine and naloxone (medicinal product) |
Has active ingredient |
True |
Buprenorphine (substance) |
Inferred relationship |
Some |
2 |
| buprenorfin för lokalt bruk |
Has active ingredient |
False |
Buprenorphine (substance) |
Inferred relationship |
Some |
|
| läkemedel som innehåller buprenorfin, för orofaryngealt bruk |
Has active ingredient |
False |
Buprenorphine (substance) |
Inferred relationship |
Some |
1 |
| Buprenorphine-containing product in parenteral dose form |
Has active ingredient |
True |
Buprenorphine (substance) |
Inferred relationship |
Some |
1 |
| Norbuprenorphine (substance) |
Is a |
False |
Buprenorphine (substance) |
Inferred relationship |
Some |
|
| Buprenorphine 20 microgram/hour prolonged-release transdermal patch |
Has active ingredient |
False |
Buprenorphine (substance) |
Inferred relationship |
Some |
|
| Buprenorphine 10 microgram/hour prolonged-release transdermal patch |
Has active ingredient |
False |
Buprenorphine (substance) |
Inferred relationship |
Some |
|
| buprenorfin 5 mikrogram per timme, depåplåster |
Has active ingredient |
False |
Buprenorphine (substance) |
Inferred relationship |
Some |
|
| läkemedel som innehåller buprenorfin och naloxon, för orofaryngealt bruk |
Has active ingredient |
False |
Buprenorphine (substance) |
Inferred relationship |
Some |
2 |
| Allergy to buprenorphine (finding) |
Causative agent |
False |
Buprenorphine (substance) |
Inferred relationship |
Some |
2 |
| Buprenorphine hydrochloride |
Is modification of (attribute) |
True |
Buprenorphine (substance) |
Inferred relationship |
Some |
|
| Product containing precisely buprenorphine (as buprenorphine hydrochloride) 400 microgram/1 each conventional release sublingual tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Buprenorphine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely buprenorphine (as buprenorphine hydrochloride) 8 milligram/1 each conventional release sublingual tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Buprenorphine (substance) |
Inferred relationship |
Some |
1 |
| Buprenorphine (as buprenorphine hydrochloride) 200 microgram sublingual tablet |
Has basis of strength substance (attribute) |
True |
Buprenorphine (substance) |
Inferred relationship |
Some |
1 |
| Buprenorphine (as buprenorphine hydrochloride) 2 mg sublingual tablet |
Has basis of strength substance (attribute) |
True |
Buprenorphine (substance) |
Inferred relationship |
Some |
1 |
| Buprenorphine-containing product in transdermal dose form |
Has active ingredient |
True |
Buprenorphine (substance) |
Inferred relationship |
Some |
1 |
| buprenorfin (som buprenorfinhydroklorid) 300 mikrogram/ml, injektionsvätska, lösning, ampull |
Has basis of strength substance (attribute) |
False |
Buprenorphine (substance) |
Inferred relationship |
Some |
1 |
| Buprenorphine 35 microgram/hour prolonged-release transdermal patch |
Has basis of strength substance (attribute) |
True |
Buprenorphine (substance) |
Inferred relationship |
Some |
1 |
| Buprenorphine 35 microgram/hour prolonged-release transdermal patch |
Has precise active ingredient |
True |
Buprenorphine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely buprenorphine 52.5 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
Has precise active ingredient |
True |
Buprenorphine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely buprenorphine 52.5 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
Has basis of strength substance (attribute) |
True |
Buprenorphine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely buprenorphine 70 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
Has basis of strength substance (attribute) |
True |
Buprenorphine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely buprenorphine 70 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
Has precise active ingredient |
True |
Buprenorphine (substance) |
Inferred relationship |
Some |
1 |
| Product containing buprenorphine in cutaneous dose form (medicinal product form) |
Has active ingredient |
True |
Buprenorphine (substance) |
Inferred relationship |
Some |
1 |
| Buprenorphine-containing product in oromucosal dose form |
Has active ingredient |
True |
Buprenorphine (substance) |
Inferred relationship |
Some |
1 |
| Buprenorphine only product |
Has active ingredient |
True |
Buprenorphine (substance) |
Inferred relationship |
Some |
1 |
| Buprenorphine and naloxone only product |
Has active ingredient |
True |
Buprenorphine (substance) |
Inferred relationship |
Some |
2 |
| Product containing only buprenorphine in parenteral dose form (medicinal product form) |
Has active ingredient |
True |
Buprenorphine (substance) |
Inferred relationship |
Some |
1 |
| Buprenorphine and naloxone only product in oromucosal dose form |
Has active ingredient |
True |
Buprenorphine (substance) |
Inferred relationship |
Some |
2 |
| Buprenorphine only product in cutaneous dose form |
Has active ingredient |
True |
Buprenorphine (substance) |
Inferred relationship |
Some |
1 |
| Buprenorphine only product in oromucosal dose form |
Has active ingredient |
True |
Buprenorphine (substance) |
Inferred relationship |
Some |
1 |
| Product containing only buprenorphine in transdermal dose form (medicinal product form) |
Has active ingredient |
True |
Buprenorphine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely buprenorphine (as buprenorphine hydrochloride) 300 microgram/1 milliliter conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Buprenorphine (substance) |
Inferred relationship |
Some |
1 |
| Allergy to buprenorphine (finding) |
Causative agent |
True |
Buprenorphine (substance) |
Inferred relationship |
Some |
1 |
| Buprenorphine 20 microgram/hour prolonged-release transdermal patch |
Has basis of strength substance (attribute) |
True |
Buprenorphine (substance) |
Inferred relationship |
Some |
1 |
| Buprenorphine 20 microgram/hour prolonged-release transdermal patch |
Has precise active ingredient |
True |
Buprenorphine (substance) |
Inferred relationship |
Some |
1 |
| Buprenorphine 10 microgram/hour prolonged-release transdermal patch |
Has precise active ingredient |
True |
Buprenorphine (substance) |
Inferred relationship |
Some |
1 |
| Buprenorphine 10 microgram/hour prolonged-release transdermal patch |
Has basis of strength substance (attribute) |
True |
Buprenorphine (substance) |
Inferred relationship |
Some |
1 |
| Buprenorphine 2 mg and naloxone hydrochloride 500 microgram sublingual tablet |
Has basis of strength substance (attribute) |
True |
Buprenorphine (substance) |
Inferred relationship |
Some |
2 |
| Buprenorphine 2 mg and naloxone hydrochloride 500 microgram sublingual tablet |
Has precise active ingredient |
True |
Buprenorphine (substance) |
Inferred relationship |
Some |
2 |
| Product containing buprenorphine and naloxone in oromucosal dose form (medicinal product form) |
Has active ingredient |
True |
Buprenorphine (substance) |
Inferred relationship |
Some |
2 |
| Buprenorphine (as buprenorphine hydrochloride) 8 mg and naloxone hydrochloride 2 mg sublingual tablet |
Has basis of strength substance (attribute) |
True |
Buprenorphine (substance) |
Inferred relationship |
Some |
2 |
| Drug addiction therapy using buprenorphine (regime/therapy) |
Using substance (attribute) |
True |
Buprenorphine (substance) |
Inferred relationship |
Some |
2 |
| Drug addiction therapy using buprenorphine and naloxone |
Using substance (attribute) |
True |
Buprenorphine (substance) |
Inferred relationship |
Some |
3 |
| Buprenorphine dependence (disorder) |
Causative agent |
True |
Buprenorphine (substance) |
Inferred relationship |
Some |
1 |
| Buprenorphine 5 microgram/hour prolonged-release transdermal patch |
Has precise active ingredient |
True |
Buprenorphine (substance) |
Inferred relationship |
Some |
1 |
| Buprenorphine 5 microgram/hour prolonged-release transdermal patch |
Has basis of strength substance (attribute) |
True |
Buprenorphine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely buprenorphine 15 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
Has precise active ingredient |
True |
Buprenorphine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely buprenorphine 15 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
Has basis of strength substance (attribute) |
True |
Buprenorphine (substance) |
Inferred relationship |
Some |
1 |
| buprenorfinhydroklorid 2 mg + naloxonhydroklorid 0,5 mg, resoriblett |
Has active ingredient |
False |
Buprenorphine (substance) |
Inferred relationship |
Some |
|
| buprenorfinhydroklorid 8 mg + naloxonhydroklorid 2 mg, resoriblett |
Has active ingredient |
False |
Buprenorphine (substance) |
Inferred relationship |
Some |
|